US Treasury proposes barring new US private investment in Chinese brain-computer interface companies

The US Treasury proposed rules on 22 October 2026 that would prohibit US persons from most new non-public investments in companies that develop or produce brain-computer interfaces and are based in, or owned or controlled from, China, Hong Kong or Macau. The definition covers invasive and non-invasive systems and their software. Brain-computer interfaces sit in the rule's prohibited tier, with no notify-only option, no technical threshold and no small-deal exemption for direct investments. Comments are due by 7 December 2026.

Market Moves

ARK Invest files to launch a BCI and surgical robotics ETF

ARK ETF Trust filed a preliminary prospectus with the US Securities and Exchange Commission on 6 November 2026 for 14 thematic ETFs, including the ARK Brain Computer Interfaces & Surgical Robotics ETF, an actively managed fund that would gain exposure primarily through total return swaps and may hold private and restricted securities.

Nov 8 · 3 min read

Market Moves

China BCI funding and IPO tracker 2026

The 2026 financing rounds and listing steps by Chinese brain-computer interface companies verified by InsideBCI, from BrainCo's RMB 2 billion round to Neuracle's STAR Market application, with amounts, lead investors and sources. Updated as new rounds are announced.

Nov 8 · 6 min read

Policy & Regulation

RAND Europe report urges rules for brain-computer interfaces in workplaces, schools and the military

A report by RAND Europe and the Brussels think tank Centre for Future Generations, released on 2 November 2026 and funded by the Open Society Foundations, finds that no brain-computer interface on sale has yet shown robust enhancement beyond normal human ability in real-world conditions, and recommends regulating the devices by where and how they are used, with a right to refuse them.

Nov 7 · 4 min read

Policy & Regulation

Brain-wearable makers left AI training on users' brain data out of their privacy policies, Science finds

A yearlong Science investigation published on 4 and 5 November 2026 found that, at first, none of the consumer neurotechnology companies building brain foundation models had disclosed it in their privacy policies, that Interaxon trained a model on about 50,000 hours of Muse users' EEG data, and that a Chinese company gives traffic police real-time access to truck drivers' brain-wave data.

Nov 7 · 6 min read

Market Moves

Three Chinese BCI companies raised RMB 1.66 billion in eight days

NeuroXess, Nanochap and Shanghai's Zhudong Technology announced rounds totalling RMB 1.664 billion between 28 October and 4 November 2026, with state-backed funds among the investors, while StairMed filed for A-share pre-listing tutoring. The 'over RMB 3 billion in a week' figure in Chinese coverage adds StairMed's financing since July.

Nov 5 · 3 min read

Market Moves

ONWARD Medical's spinal stimulator sales stalled in the third quarter

ONWARD Medical reported EUR 2.5 million of revenue for the third quarter of 2026 on 3 November, up from EUR 1.7 million a year earlier, but ARC-EX product revenue of EUR 2.0 million and 88 units were roughly level with the second quarter. The shares closed about 11.5 per cent lower in Brussels and KBC Securities cut its rating to hold.

Nov 5 · 4 min read

Market Moves

BrainCo is developing a brain-stimulation wearable it pitches as an electronic GLP-1

Hangzhou-based BrainCo is developing a wearable that it says could suppress appetite through brain stimulation, founding partner Nyx He told Bloomberg in an interview published on 3 November 2026, and aims to bring it to market within two to three years, starting in China. BrainCo has not named the device, given technical details or published any trial data.

Nov 4 · 4 min read

Market Moves

Chinese vision-implant maker Nanochap raises RMB 500 million

Hangzhou-based Nanochap Electronics said on 3 November 2026 that it had closed a RMB 500 million Series C+ round led by Gaorong Ventures, its second round of 2026, bringing its total funding to RMB 1 billion. The company is running a registration trial of a 320-channel retinal implant that it says has been placed in three blind patients.

Nov 4 · 3 min read